T cell exhaustion during persistent viral infections
- PMID: 25620767
- PMCID: PMC4424083
- DOI: 10.1016/j.virol.2014.12.033
T cell exhaustion during persistent viral infections
Abstract
Although robust and highly effective anti-viral T cells contribute to the clearance of many acute infections, viral persistence is associated with the development of functionally inferior, exhausted, T cell responses. Exhaustion develops in a step-wise and progressive manner, ranges in severity, and can culminate in the deletion of the anti-viral T cells. This disarming of the response is consequential as it compromises viral control and potentially serves to dampen immune-mediated damage. Exhausted T cells are unable to elaborate typical anti-viral effector functions. They are characterized by the sustained upregulation of inhibitory receptors and display a gene expression profile that distinguishes them from prototypic effector and memory T cell populations. In this review we discuss the properties of exhausted T cells; the virological and immunological conditions that favor their development; the cellular and molecular signals that sustain the exhausted state; and strategies for preventing and reversing exhaustion to favor viral control.
Keywords: Cytokines; Immunity; Inhibitory receptors; Persistent infections; T cell exhaustion.
Copyright © 2014 Elsevier Inc. All rights reserved.
Figures



References
-
- Abrams D, Lévy Y, Losso MH, Babiker A, Collins G, Cooper DA, Darbyshire J, Emery S, Fox L, Gordin F, Lane HC, Lundgren JD, Mitsuyasu R, Neaton JD, Phillips A, Routy JP, Tambussi G, Wentworth D, INSIGHT-ESPRIT Study Group, SILCAAT Scientific Committee Interleukin-2 therapy in patients with HIV infection. N. Engl. J. Med. 2009;361:1548–1559. doi:10.1056/NEJMoa0903175. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
- AI109962/AI/NIAID NIH HHS/United States
- AI105343/AI/NIAID NIH HHS/United States
- AI082966/AI/NIAID NIH HHS/United States
- T32 AI007051/AI/NIAID NIH HHS/United States
- AI112521/AI/NIAID NIH HHS/United States
- R56 AI049360/AI/NIAID NIH HHS/United States
- U19 AI109962/AI/NIAID NIH HHS/United States
- R01 AI049360/AI/NIAID NIH HHS/United States
- AI082630/AI/NIAID NIH HHS/United States
- U01 AI082966/AI/NIAID NIH HHS/United States
- AI049360/AI/NIAID NIH HHS/United States
- U19 AI082630/AI/NIAID NIH HHS/United States
- P01 AI112521/AI/NIAID NIH HHS/United States
- AI095608/AI/NIAID NIH HHS/United States
- HHSN266200500030C/PHS HHS/United States
- R01 AI105343/AI/NIAID NIH HHS/United States
- U01 AI095608/AI/NIAID NIH HHS/United States
- HHSN266200500030C/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical